Clinical Trial Update: Study to Evaluate Safety and Efficacy of Oral MP1032 in Psoriasis Patients [Phase 2]

View source ↗

Summary

Phase 2 study of oral MP1032 in psoriasis patients has completed and results have been posted. The trial evaluated safety and efficacy in plaque psoriasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis
• Psoriasis

Drugs mentioned

• MP1032

Snippet

Sponsor: MetrioPharm AG | Conditions: Psoriasis, Plaque Psoriasis | Phase 2 | Status: COMPLETED | Results posted: 2019-01-23